Phosphatidylserine phospholipase A1 enables GPR34-dependent immune cell accumulation in the peritoneal cavity
Journal of Experimental Medicine · 2024
DOI: 10.1084/jem.20240992 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Experimental Medicine, 2024. Verfasst von Hanson Tam und 6 weiteren Autor:innen. Beteiligte Einrichtung: Howard Hughes Medical Institute, University of California, San Francisco , San Francisco, CA, USA. Hauptthemen laut MEDLINE: Peritoneal Cavity, Phospholipases A1. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 61 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIH HHS, NCI NIH HHS, NIDDK NIH HHS.
Abstract (Originalsprache)
The peritoneal cavity (PerC) is an important site for immune responses to infection and cancer metastasis. Yet few ligand–receptor axes are known to preferentially govern immune cell accumulation in this compartment. GPR34 is a lysophosphatidylserine (lysoPS)-responsive receptor that frequently harbors gain-of-function mutations in mucosa-associated B cell lymphoma. Here, we set out to test the impact of a GPR34 knock-in (KI) allele in the B-lineage. We report that GPR34 KI promotes the PerC accumulation of plasma cells (PC) and memory B cells (MemB). These KI cells migrate robustly to lysoPS ex vivo, and the KI allele synergizes with a Bcl2 transgene to promote MemB but not PC accumulation. Gene expression and labeling studies reveal that GPR34 KI enhances PerC MemB proliferation. Both KI PC and MemB are specifically enriched at the omentum, a visceral adipose tissue containing fibroblasts that express the lysoPS-generating PLA1A enzyme. Adoptive transfer and chimera experiments revealed that KI PC and MemB maintenance in the PerC is dependent on stromal PLA1A. These findings provide in vivo evidence that PLA1A produces lysoPS that can regulate GPR34-mediated immune cell accumulation at the omentum.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Howard Hughes Medical Institute, University of California, San Francisco , San Francisco, CA, USA.
- Department of Microbiology and Immunology, University of California, San Francisco, San Francisco, CA, USA.
- Medical Scientist Training Program, University of California, San Francisco , San Francisco, CA, USA.
- Rudolf Schönheimer Institute of Biochemistry, Molecular Biochemistry, Medical Faculty, University of Leipzig , Leipzig, Germany.
- Lymphoid Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health , Bethesda, MD, USA.
ORCID-Profile: Hanson Tam, Ying Xu, Jinping An, Torsten Schöneberg, Angela Schulz, Jagan R Muppidi, Jason G Cyster
Förderung
- NIH HHS
- NCI NIH HHS
- NIDDK NIH HHS
- NIGMS NIH HHS
- NIAID NIH HHS
- Howard Hughes Medical Institute
- University of California, San Francisco
- National Institutes of Health
Zitieren
APA
Tam, H., Xu, Y., An, J., Schöneberg, T., Schulz, A., Muppidi, J. R., & Cyster, J. G. (2024). Phosphatidylserine phospholipase A1 enables GPR34-dependent immune cell accumulation in the peritoneal cavity. Journal of Experimental Medicine. https://doi.org/10.1084/jem.20240992
Vancouver
Tam H, Xu Y, An J, Schöneberg T, Schulz A, Muppidi JR, et al. Phosphatidylserine phospholipase A1 enables GPR34-dependent immune cell accumulation in the peritoneal cavity. Journal of Experimental Medicine. 2024. doi:10.1084/jem.20240992
BibTeX
@article{Tam2024,
author = {Tam, Hanson and Xu, Ying and An, Jinping and Schöneberg, Torsten and Schulz, Angela and Muppidi, Jagan R and Cyster, Jason G},
title = {Phosphatidylserine phospholipase A1 enables GPR34-dependent immune cell accumulation in the peritoneal cavity},
journal = {Journal of Experimental Medicine},
year = {2024},
doi = {10.1084/jem.20240992}
}
EUVIMED